CDC Centers for Disease Control and Prevention,updates

April 2, 2020This message includes updates on the COVID-19 response from CDC. The COVID-19 Outbreak is a rapidly evolving situation and information will be updated on the COVID-19 Situation Summary as it becomes available.

What's New

Disinfecting Your Facility if Someone is SickWEDNESDAY, APRIL 1, 2020 (UPDATED) Healthcare Infection Prevention and Control FAQs for COVID-19WEDNESDAY, APRIL 1, 2020 (UPDATED) Communication Resources for Travelers WEDNESDAY, APRIL 1, 2020 (UPDATED) Resources to Support People Experiencing HomelessnessWEDNESDAY, APRIL 1, 2020 (UPDATED) Public Service Announcements (PSAs)WEDNESDAY, APRIL 1, 2020 (NEW) More Updates

Resources and Guidance

Communities, Schools, and Businesses People at Higher Risk for Severe Illness Travel State and Local Public Health Professionals Healthcare Professionals Laboratories Resources in American Sign Language (New Videos Available)

Coronavirus Disease 2019 (COVID-19) in the U.S.

As of April 2, 2020 In the United States, there have been 213,144 confirmed cases of COVID-19 detected through U.S. public health surveillance systems in 50 states and the District of Columbia, Puerto Rico, Guam, the Northern Marianas Islands, and U.S. Virgin Islands.  CDC provides updated U.S. case information online daily.	U.S. Cases

C. diff Infection and Associated Hospitalizations in the U.S. Decreased During 2011-2017  A new CDC report, published in the New England Journal of Medicine, shows Clostridioides difficile (C. diff) infection (CDI) and associated hospitalizations in the United States decreased during 2011-2017. The report, Trends in U.S. Burden of Clostridioides difficile Infection and Outcomes, shows that total cases of CDI decreased 24% after adjusting the data for the use of a more sensitive type of test called nucleic acid amplification tests (NAAT). This overall decrease was driven by a 36% decrease in healthcare-associated cases (those that happen in a healthcare facility or associated with recent admission to a healthcare facility), while community-associated CDI (those that happen in the community, outside of healthcare facilities) did not change. After adjusting for NAAT use, hospitalizations as a result of CDI also decreased by 24%. There were no changes in the estimates of first recurrences (people who get C. diff again within 2-8 weeks after their first infection) and in-hospital deaths.  Preventing C. diff infections is a national priority. Efforts to improve infection prevention and antibiotic and diagnostic stewardship continue to expand across healthcare settings, particularly in hospitals. Enhanced prevention strategies that target healthcare- and community-associated CDI may further reduce the overall infection rate. Improving outpatient antibiotic use can also help reduce antibiotic-associated adverse events like CDI and improve patient safety. Learn more about what you can do to prevent C. diff: https://www.cdc.gov/cdiff/. New CDC data in @NEJM show C. diff infection and associated hospitalizations in the U.S. decreased during 2011-2017 due to a decline in healthcare-associated #Cdiff. https://doi.org/10.1056/NEJMoa1910215